Mark Gustavson

1.1k total citations
30 papers, 813 citations indexed

About

Mark Gustavson is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Mark Gustavson has authored 30 papers receiving a total of 813 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Oncology, 17 papers in Molecular Biology and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Mark Gustavson's work include HER2/EGFR in Cancer Research (16 papers), Molecular Biology Techniques and Applications (5 papers) and Monoclonal and Polyclonal Antibodies Research (4 papers). Mark Gustavson is often cited by papers focused on HER2/EGFR in Cancer Research (16 papers), Molecular Biology Techniques and Applications (5 papers) and Monoclonal and Polyclonal Antibodies Research (4 papers). Mark Gustavson collaborates with scholars based in United States, United Kingdom and Spain. Mark Gustavson's co-authors include Howard C. Crawford, Barbara Fingleton, Lynn M. Matrisian, Jason Christiansen, David L. Rimm, Natasza A. Kurpios, John A. Hassell, Rebecca A. Wagenaar-Miller, Marisa Dolled‐Filhart and Annette M. Molinaro and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Molecular and Cellular Biology.

In The Last Decade

Mark Gustavson

30 papers receiving 800 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mark Gustavson United States	17	393	359	243	155	149	30	813
Lorena de la Peña Spain	11	345 0.9×	419 1.2×	261 1.1×	210 1.4×	143 1.0×	37	787
Rosa I. Gallagher United States	15	413 1.1×	345 1.0×	184 0.8×	111 0.7×	160 1.1×	27	808
Joerg Schwock Canada	17	404 1.0×	290 0.8×	216 0.9×	193 1.2×	75 0.5×	36	934
Veronique Neumeister United States	17	510 1.3×	496 1.4×	319 1.3×	170 1.1×	104 0.7×	35	968
Shaoyan Xi China	20	540 1.4×	298 0.8×	330 1.4×	179 1.2×	107 0.7×	60	1.1k
Yoko S. DeRose United States	9	439 1.1×	699 1.9×	342 1.4×	141 0.9×	57 0.4×	10	1.1k
Janna Paulsson Sweden	19	748 1.9×	703 2.0×	398 1.6×	292 1.9×	102 0.7×	21	1.5k
Satyen H. Gohil United Kingdom	14	546 1.4×	343 1.0×	226 0.9×	60 0.4×	47 0.3×	30	966
Frank J. Lowery United States	14	565 1.4×	580 1.6×	140 0.6×	197 1.3×	70 0.5×	26	1.1k
Magüi Gili Spain	5	763 1.9×	557 1.6×	159 0.7×	179 1.2×	176 1.2×	6	1.1k

Countries citing papers authored by Mark Gustavson

Since Specialization

Citations

This map shows the geographic impact of Mark Gustavson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Gustavson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Gustavson more than expected).

Fields of papers citing papers by Mark Gustavson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Gustavson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Gustavson. The network helps show where Mark Gustavson may publish in the future.

Co-authorship network of co-authors of Mark Gustavson

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Gustavson. A scholar is included among the top collaborators of Mark Gustavson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Gustavson. Mark Gustavson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Brieu, Nicolas, Anatoliy Shumilov, Armin Meier, et al.. (2024). HER2 quantitative continuous scoring for accurate patient selection in HER2 negative trastuzumab deruxtecan treated breast cancer. Scientific Reports. 14(1). 12129–12129. 16 indexed citations

Meric‐Bernstam, Funda, et al.. (2022). A phase 2, multicenter, open-label study evaluating trastuzumab deruxtecan (T-DXd) for the treatment of select human epidermal growth factor receptor 2 (HER2)-expressing solid tumors (DESTINY-PanTumor02).. Journal of Clinical Oncology. 40(4_suppl). TPS623–TPS623. 2 indexed citations

Li, Bob T., Funda Meric‐Bernstam, Soham D. Puvvada, et al.. (2021). A phase 2, multicenter, open-label study evaluating trastuzumab deruxtecan (T-DXd) for the treatment of solid tumors harboring specific HER2-activating mutations (DESTINY-PanTumor01).. Journal of Clinical Oncology. 39(15_suppl). TPS3162–TPS3162. 4 indexed citations

Gustavson, Mark, Franco Cecchi, Sriram Sridhar, et al.. (2021). Abstract PD6-01: Novel approach to HER2 quantification: Digital pathology coupled with AI-based image and data analysis delivers objective and quantitative HER2 expression analysis for enrichment of responders to trastuzumab deruxtecan (T-DXd; DS-8201), specifically in HER2-low patients. Cancer Research. 81(4_Supplement). PD6–1. 18 indexed citations

Bartlett, John M.S., Mark Gustavson, David L. Rimm, et al.. (2015). Validation of the IHC4 Breast Cancer Prognostic Algorithm Using Multiple Approaches on the Multinational TEAM Clinical Trial. Archives of Pathology & Laboratory Medicine. 140(1). 66–74. 25 indexed citations

Romeo, Elisa, et al.. (2012). Company Profile: Historx: Tissue-Based Diagnostic Solutions for Personalized Medicine. Personalized Medicine. 9(2). 185–190. 1 indexed citations

Dolled‐Filhart, Marisa & Mark Gustavson. (2012). Tissue microarrays and quantitative tissue-based image analysis as a tool for oncology biomarker and diagnostic development. Expert Opinion on Medical Diagnostics. 6(6). 569–583. 4 indexed citations

Chakravarti, Arnab, Meihua Wang, H. Ian Robins, et al.. (2012). RTOG 0211: A Phase 1/2 Study of Radiation Therapy With Concurrent Gefitinib for Newly Diagnosed Glioblastoma Patients. International Journal of Radiation Oncology*Biology*Physics. 85(5). 1206–1211. 122 indexed citations

Christiansen, Jason, John M.S. Bartlett, Mark Gustavson, et al.. (2012). Validation of IHC4 algorithms for prediction of risk of recurrence in early breast cancer using both conventional and quantitative IHC approaches.. Journal of Clinical Oncology. 30(15_suppl). 517–517. 7 indexed citations

10.

Mascaux, Céline, Murry W. Wynes, Yasufumi Kato, et al.. (2011). EGFR Protein Expression in Non–Small Cell Lung Cancer Predicts Response to an EGFR Tyrosine Kinase Inhibitor—A Novel Antibody for Immunohistochemistry or AQUA Technology. Clinical Cancer Research. 17(24). 7796–7807. 29 indexed citations

11.

Baquero, Maria T., Mark Gustavson, Robert L. Camp, et al.. (2011). Evaluation of prognostic and predictive value of microtubule associated protein tau in two independent cohorts. Breast Cancer Research. 13(5). R85–R85. 36 indexed citations

12.

Anagnostou, Valsamo, Anastasios Dimou, Taxiarchis Botsis, et al.. (2011). Molecular classification of nonsmall cell lung cancer using a 4‐protein quantitative assay. Cancer. 118(6). 1607–1618. 24 indexed citations

13.

Faratian, Dana, Jason Christiansen, Mark Gustavson, et al.. (2011). Heterogeneity Mapping of Protein Expression in Tumors using Quantitative Immunofluorescence. Journal of Visualized Experiments. e3334–e3334. 24 indexed citations

14.

Faratian, Dana, et al.. (2011). Heterogeneity Mapping of Protein Expression in Tumors using Quantitative Immunofluorescence. Journal of Visualized Experiments. 5 indexed citations

15.

Anagnostou, Valsamo, Jennifer M. Giltnane, Summar Siddiqui, et al.. (2010). Analytic Variability in Immunohistochemistry Biomarker Studies. Cancer Epidemiology Biomarkers & Prevention. 19(4). 982–991. 67 indexed citations

16.

Dolled‐Filhart, Marisa, Mark Gustavson, Robert L. Camp, et al.. (2010). Automated Analysis of Tissue Microarrays. Methods in molecular biology. 664. 151–162. 33 indexed citations

17.

Holzer, Timothy R., Kathleen M. Heinz-Taheny, Darryl Ballard, et al.. (2010). Abstract B31: Potential for patient tailoring for prodrug of gemcitabine (LY2334737) by assessment carboxylesterase II expression in solid tumor biopsies. Clinical Cancer Research. 16(14_Supplement). B31–B31. 2 indexed citations

18.

Gustavson, Mark, Melissa A. Cregger, Jane Mayotte, et al.. (2009). Standardization of HER2 immunohistochemistry in breast cancer by automated quantitative analysis.. Archives of Pathology & Laboratory Medicine. 133(9). 1413–1419. 46 indexed citations

19.

Gustavson, Mark, et al.. (2009). Development of an Unsupervised Pixel-based Clustering Algorithm for Compartmentalization of Immunohistochemical Expression Using Automated QUantitative Analysis. Applied immunohistochemistry & molecular morphology. 17(4). 329–337. 32 indexed citations

20.

Gustavson, Mark, Howard C. Crawford, Barbara Fingleton, & Lynn M. Matrisian. (2004). Tcf binding sequence and position determines β‐catenin and Lef‐1 responsiveness of MMP‐7 promoters. Molecular Carcinogenesis. 41(3). 125–139. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact